Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Open in API
Filings indexed 574 across all filing types
Latest filing 2020-09-03 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1880 characters) and contains the header 'RNS Number : 9983X'. The content describes a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly mentions that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This structure strongly indicates a general regulatory announcement or market notice rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement distributed via the RNS system, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such notices.
2020-09-03 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is an official notification released via RNS (Regulatory News Service) from the London Stock Exchange. The content explicitly discusses the 'Total Voting Rights' and the total number of Ordinary Shares in issue (56,854,039), referencing compliance with DTR 5.6.1 (Disclosure Guidance and Transparency Rules). This type of announcement, which updates the market on the total share count used as a denominator for ownership notifications, is a standard regulatory disclosure. While it relates to share capital changes, its primary function here is a mandatory disclosure of voting rights status, which fits best under the general 'Regulatory Filings' (RNS) category, as it is not a specific announcement of a dividend (DIV), share issue (SHA), or transaction in own shares (POS), but rather a compliance update on the total outstanding shares.
2020-09-01 English
Exercise of Warrants
Share Issue/Capital Change Classification · 1% confidence The document is identified by the RNS Number header and contains information typical of a regulatory news service announcement from the London Stock Exchange. The content details the 'Exercise of Warrants' resulting in new share issuance and provides an update on the total voting rights, mentioning that a 'Total Voting Rights announcement will be released by the Company on 1 September 2020.' The core subject is a capital structure change (issuance of shares following warrant exercise) and a notification related to share capital size. This fits best under 'Share Issue/Capital Change' (SHA) or potentially a general 'Regulatory Filing' (RNS). Since the primary action is the issuance of new shares due to warrant exercise, SHA is the most specific fit, as it relates directly to capital structure changes. The document length is short (3746 chars) and it is a direct announcement, not a detailed report.
2020-08-28 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document explicitly starts with 'RNS Number : 7357W' and contains the header 'NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)'. It details changes in voting rights percentages (crossing thresholds) by a specific entity ('Monecor (London) Limited') concerning the issuer ('ValiRx PLC'). This structure is characteristic of a regulatory filing concerning insider/major shareholder transactions or holdings changes, which aligns with the definition of 'Director's Dealing' (DIRS) or, more broadly, a notification filed via the Regulatory News Service (RNS). Since the form is specifically 'TR-1: Standard form for notification of major holdings', and the document is distributed via RNS, the most precise classification among the provided options that captures this regulatory notification context is 'Major Shareholding Notification' (MRQ) or the general regulatory fallback 'RNS'. Given the specific content detailing the crossing of a major holding threshold (6.51%), MRQ is highly appropriate. However, since the document is explicitly distributed via RNS and is a standard regulatory notification form, RNS serves as a strong general category for such official announcements. Comparing MRQ (Major Shareholding Notification) and DIRS (Director's Dealing), this is a notification by a shareholder/entity, not necessarily a director, making MRQ a better fit than DIRS. Since RNS is the distribution mechanism and a general regulatory filing category, and MRQ is very specific to this type of holding change, I will select MRQ as it is more specific than RNS, but acknowledge the RNS distribution.
2020-08-20 English
Block Listing Application and Company Update
Share Issue/Capital Change Classification · 1% confidence The document begins with 'RNS Number : 5089W' and is explicitly stated to be information provided by 'RNS, the news service of the London Stock Exchange.' The content details a Block Listing Application, updates on financing warrants, and clinical program updates. While it contains financial and corporate actions, its primary nature is a regulatory announcement disseminated via the RNS system. Since it is not a full annual report (10-K), an earnings release (ER), or a specific capital change announcement (like SHA or CAP, although it mentions a fundraise), the most appropriate general category for a standard, timely regulatory disclosure distributed through the official news service is Regulatory Filings (RNS). The document length (7177 chars) is substantial enough that it is not merely an announcement *about* a report, but the report itself, which is a regulatory filing.
2020-08-19 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 3777W' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification. Although it is distributed via RNS (London Stock Exchange news service), the core content is a specific regulatory disclosure about shareholdings, matching the 'Major Shareholding Notification' (MRQ) category better than the general 'RNS' fallback. The content details the acquisition/disposal of voting rights by SPREADEX LTD, crossing a threshold on 07/08/2020.
2020-08-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.